FIELD: medicine.
SUBSTANCE: group of inventions relates to a method of treating eye diseases. Method of treating subjects with a clinical diagnosis of moderate to severe blepharitis involves applying to said subjects a composition in an effective amount containing from 0.05% to 1% of pimecrolimus, where the subjects to be treated have moderate to severe blepharitis signs and symptoms, characterized by the presence of eyelid oedema, debris and eye discomfort. Also disclosed is an alternative method of treating blepharitis.
EFFECT: group of inventions provides effective treatment of moderate to severe blepharitis.
4 cl, 10 dwg, 11 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DISEASE TREATMENT | 2020 |
|
RU2816363C2 |
METHOD FOR EVALUATION OF EFFICIENCY OF TREATMENT OF CHRONIC BLEPHARITIS BY LASER DOPPLER FLOWMETRY | 2017 |
|
RU2644699C1 |
GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
METHOD OF "DRY EYE" SYNDROME TREATMENT | 2014 |
|
RU2546922C1 |
OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE DAMAGE AND DRY EYE SYMPTOMS | 2019 |
|
RU2806212C2 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
COMPOSITION FOR HYGIENIC TREATMENT OF THE EYELIDS | 2021 |
|
RU2778503C1 |
COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
PREPARATION "DEMALAN-AKTIV" FOR DEMODECOSIS TREATMENT | 2006 |
|
RU2313356C1 |
Authors
Dates
2024-09-30—Published
2020-05-20—Filed